Lawrence N. Barrera

Norwich Research Park
Norwich, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer.

NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancer.

Journal: Journal of the National Cancer Institute

Published: February 17, 2025

Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.

Scribble Deficiency Promotes Pancreatic Ductal Adenocarcinoma Development and Metastasis.

Journal: Cancer research

Published: November 06, 2023

The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis.

The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis.

Journal: Journal of physiology and biochemistry

Published: November 26, 2021

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs.

Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs.

Journal: Journal of physiology and biochemistry

Published: May 12, 2021

Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.

Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.

Journal: Cancer research

Published: November 22, 2019

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis.

Journal: The Journal of pathology

Published: May 01, 2015

Understanding life and death decisions in human leukaemias.

Understanding life and death decisions in human leukaemias.

Journal: Biochemical Society transactions

Published: August 12, 2014

BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB.

BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB.

Journal: Cellular signalling

Published: July 24, 2012

Bortezomib induces heme oxygenase-1 expression in multiple myeloma.

Bortezomib induces heme oxygenase-1 expression in multiple myeloma.

Journal: Cell cycle (Georgetown, Tex.)

Published: May 24, 2012

Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro.

Colorectal cancer cells Caco-2 and HCT116 resist epigenetic effects of isothiocyanates and selenium in vitro.

Journal: European journal of nutrition

Published: April 16, 2012

TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death.

TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death.

Journal: Biochimica et biophysica acta

Published: April 13, 2012

Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention.

Epigenetic and antioxidant effects of dietary isothiocyanates and selenium: potential implications for cancer chemoprevention.

Journal: The Proceedings of the Nutrition Society

Published: March 07, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026